Evolent Health Inc (EVH) - Net Assets
Based on the latest financial reports, Evolent Health Inc (EVH) has net assets worth $396.39 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.88 Billion) and total liabilities ($1.48 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Evolent Health Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $396.39 Million |
| % of Total Assets | 21.1% |
| Annual Growth Rate | 40.06% |
| 5-Year Change | -40.14% |
| 10-Year Change | -54.48% |
| Growth Volatility | 145.62 |
Evolent Health Inc - Net Assets Trend (2012–2025)
This chart illustrates how Evolent Health Inc's net assets have evolved over time, based on quarterly financial data. See EVH cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Evolent Health Inc (2012–2025)
The table below shows the annual net assets of Evolent Health Inc from 2012 to 2025. For live valuation and market cap data, see Evolent Health Inc market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $415.19 Million | -58.53% |
| 2024-12-31 | $1.00 Billion | -6.22% |
| 2023-12-31 | $1.07 Billion | +24.24% |
| 2022-12-31 | $859.42 Million | +23.90% |
| 2021-12-31 | $693.63 Million | +11.95% |
| 2020-12-31 | $619.60 Million | -33.31% |
| 2019-12-31 | $929.05 Million | -21.89% |
| 2018-12-31 | $1.19 Billion | +13.67% |
| 2017-12-31 | $1.05 Billion | +14.71% |
| 2016-12-31 | $912.11 Million | -2.40% |
| 2015-12-31 | $934.58 Million | +45248.74% |
| 2014-12-31 | $-2.07 Million | -106.67% |
| 2013-12-31 | $31.04 Million | +496.89% |
| 2012-12-31 | $5.20 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Evolent Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 129474400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.18 Million | 0.28% |
| Other Comprehensive Income | $-2.62 Million | -0.63% |
| Other Components | $1.73 Billion | 417.15% |
| Total Equity | $415.19 Million | 100.00% |
Evolent Health Inc Competitors by Market Cap
The table below lists competitors of Evolent Health Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
D&O Home Collection Co Ltd
SHE:002798
|
$470.33 Million |
|
Shandong Xingmin Wheel Co Ltd
SHE:002355
|
$470.51 Million |
|
Hunan Lead Power Dazhi Technology Inc Co
SHE:300530
|
$470.53 Million |
|
Asante Gold Corporation
F:1A9
|
$470.59 Million |
|
KENGIC Intelligent Technology Co. Ltd. A
SHG:688455
|
$470.13 Million |
|
ROPEOK Technology Group Co Ltd
SHG:688619
|
$469.99 Million |
|
Beijing Changjiu Logistics Ltd
SHG:603569
|
$469.82 Million |
|
Yulon Nissan Motor Co Ltd
TW:2227
|
$469.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Evolent Health Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,001,259,000 to 415,194,000, a change of -586,065,000 (-58.5%).
- Net loss of 534,510,000 reduced equity.
- Dividend payments of 11,127,000 reduced retained earnings.
- Share repurchases of 39,996,000 reduced equity.
- Other comprehensive income decreased equity by 871,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-534.51 Million | -128.74% |
| Dividends Paid | $11.13 Million | -2.68% |
| Share Repurchases | $40.00 Million | -9.63% |
| Other Comprehensive Income | $-871.00K | -0.21% |
| Other Changes | $439.00K | +0.11% |
| Total Change | $- | -58.53% |
Book Value vs Market Value Analysis
This analysis compares Evolent Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.28x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 34.32x to 1.28x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $0.14 | $4.67 | x |
| 2013-12-31 | $0.81 | $4.67 | x |
| 2014-12-31 | $-0.05 | $4.67 | x |
| 2015-12-31 | $14.07 | $4.67 | x |
| 2016-12-31 | $20.26 | $4.67 | x |
| 2017-12-31 | $16.26 | $4.67 | x |
| 2018-12-31 | $15.38 | $4.67 | x |
| 2019-12-31 | $11.20 | $4.67 | x |
| 2020-12-31 | $7.30 | $4.67 | x |
| 2021-12-31 | $8.06 | $4.67 | x |
| 2022-12-31 | $9.17 | $4.67 | x |
| 2023-12-31 | $9.60 | $4.67 | x |
| 2024-12-31 | $8.73 | $4.67 | x |
| 2025-12-31 | $3.64 | $4.67 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Evolent Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -128.74%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -28.49%
- • Asset Turnover: 0.99x
- • Equity Multiplier: 4.57x
- Recent ROE (-128.74%) is below the historical average (-37.30%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -370.37% | -230.81% | 0.51x | 3.13x | $-19.78 Million |
| 2013 | 64.50% | 78.00% | 0.25x | 3.28x | $16.92 Million |
| 2014 | 0.00% | -25.02% | 2.64x | 0.00x | $-25.04 Million |
| 2015 | 51.20% | 343.21% | 0.10x | 1.56x | $267.56 Million |
| 2016 | -17.51% | -62.84% | 0.21x | 1.32x | $-250.95 Million |
| 2017 | -5.80% | -13.95% | 0.33x | 1.25x | $-165.30 Million |
| 2018 | -4.43% | -8.40% | 0.36x | 1.45x | $-171.59 Million |
| 2019 | -32.74% | -43.95% | 0.46x | 1.62x | $-394.21 Million |
| 2020 | -53.95% | -36.15% | 0.63x | 2.38x | $-396.21 Million |
| 2021 | -5.42% | -4.14% | 0.64x | 2.05x | $-106.96 Million |
| 2022 | -2.23% | -1.42% | 0.74x | 2.11x | $-105.11 Million |
| 2023 | -10.59% | -5.76% | 0.73x | 2.51x | $-219.81 Million |
| 2024 | -6.15% | -2.41% | 1.00x | 2.54x | $-161.75 Million |
| 2025 | -128.74% | -28.49% | 0.99x | 4.57x | $-576.03 Million |
Industry Comparison
This section compares Evolent Health Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $382,015,314
- Average return on equity (ROE) among peers: -181.89%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Evolent Health Inc (EVH) | $396.39 Million | -370.37% | 3.74x | $470.17 Million |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.81 Million |
| American Well Corp (AMWL) | $374.94 Million | -23.25% | 0.33x | $128.02 Million |
| Heartbeam Inc (BEAT) | $2.37 Million | -540.31% | 0.70x | $38.42 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $4.96 Million | -140.89% | 0.12x | $6.51 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $800.46 Million | 6.22% | 5.89x | $10.63 Billion |
| Carlsmed, Inc. Common Stock (CARL) | $-46.13 Million | 0.00% | 0.00x | $271.31 Million |
| CareCloud, Inc. (CCLD) | $97.93 Million | 2.90% | 0.44x | $93.06 Million |
| Certara Inc (CERT) | $822.13 Million | -6.01% | 0.54x | $959.61 Million |
| CareMax Inc (CMAX) | $61.44 Million | -1112.15% | 9.14x | $381.50 |
| Claritev Corporation (CTEV) | $1.71 Billion | -5.37% | 3.08x | $460.29 Million |
About Evolent Health Inc
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics an… Read more